RESTANTE, GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 1.185
EU - Europa 386
AS - Asia 260
AF - Africa 39
OC - Oceania 11
SA - Sud America 3
Totale 1.884
Nazione #
US - Stati Uniti d'America 1.155
IT - Italia 189
CN - Cina 132
SG - Singapore 76
SE - Svezia 59
BG - Bulgaria 46
DE - Germania 34
CA - Canada 28
CI - Costa d'Avorio 27
GB - Regno Unito 20
VN - Vietnam 19
AU - Australia 9
TR - Turchia 9
FR - Francia 8
AT - Austria 7
KR - Corea 6
NL - Olanda 6
BE - Belgio 5
IN - India 5
NG - Nigeria 5
HK - Hong Kong 4
RU - Federazione Russa 4
SN - Senegal 4
BF - Burkina Faso 3
JP - Giappone 3
LT - Lituania 3
BR - Brasile 2
NZ - Nuova Zelanda 2
PL - Polonia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IL - Israele 1
MX - Messico 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 1.884
Città #
Fairfield 164
Houston 127
Woodbridge 109
Santa Clara 87
Chandler 84
Ashburn 72
Seattle 71
Cambridge 56
Serra 47
Sofia 46
Wilmington 41
Shanghai 38
Pisa 33
Singapore 33
Ann Arbor 32
New York 30
Abidjan 27
Princeton 26
Ottawa 22
Florence 21
Boardman 20
Lawrence 18
Beijing 17
Frankfurt am Main 15
Medford 15
Dearborn 12
London 12
Dong Ket 10
Des Moines 9
Istanbul 8
Boulder 7
Nanjing 7
Fuzhou 6
Iowa City 6
Los Angeles 6
Redwood City 6
Turin 6
Vienna 6
Chiesina Uzzanese 5
Columbus 5
Kunming 5
Lagos 5
Bremen 4
Brussels 4
Dakar 4
Hefei 4
Hong Kong 4
Norwalk 4
Quanzhou 4
San Diego 4
San Francisco 4
Washington 4
Guangzhou 3
Nuremberg 3
Phoenix 3
Pistoia 3
Toronto 3
Bientina 2
Caserta 2
Changsha 2
Hebei 2
Jiaxing 2
Kilburn 2
Kolkata 2
Lucca 2
Milan 2
Montréal 2
Palermo 2
Perth 2
Polska 2
Seoul 2
Shenyang 2
Amsterdam 1
Auckland 1
Azor 1
Bangkok 1
Baoding 1
Bari 1
Bukhara 1
Cagliari 1
Camaiore 1
Castelnuovo Rangone 1
Chehalis 1
Chengdu 1
Chicago 1
Daejeon 1
Dallas 1
Daly City 1
Diemen 1
Diyarbakir 1
Dubai 1
Esslingen am Neckar 1
Freitas 1
Gatineau 1
Göttingen 1
Hangzhou 1
Huzhou 1
Indiana 1
Kent 1
Langfang 1
Totale 1.485
Nome #
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 249
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 130
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response 128
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment 120
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase. 117
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment 114
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 113
From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 105
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy 105
Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumors 103
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 99
Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: A case report with pharmacogenetic analysis to personalize treatment 91
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 87
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 79
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 75
null 70
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells 67
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 63
Genome Wide Association Studies (GWAS) 45
Totale 1.960
Categoria #
all - tutte 6.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.529


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020189 0 0 0 0 0 0 48 47 43 17 29 5
2020/2021143 9 13 4 13 6 10 12 9 19 13 12 23
2021/2022173 3 3 3 3 36 30 8 6 13 5 6 57
2022/2023307 29 46 22 13 25 31 1 27 80 0 31 2
2023/2024206 12 12 42 8 19 40 6 6 3 13 25 20
2024/2025235 9 19 10 43 77 57 20 0 0 0 0 0
Totale 1.960